CN104307208A - 一种富集纯化血小板的方法 - Google Patents
一种富集纯化血小板的方法 Download PDFInfo
- Publication number
- CN104307208A CN104307208A CN201410508458.8A CN201410508458A CN104307208A CN 104307208 A CN104307208 A CN 104307208A CN 201410508458 A CN201410508458 A CN 201410508458A CN 104307208 A CN104307208 A CN 104307208A
- Authority
- CN
- China
- Prior art keywords
- centrifugal
- minutes
- layer
- enriched substance
- red blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 96
- 210000001772 blood platelet Anatomy 0.000 title claims abstract description 59
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 55
- 210000004369 blood Anatomy 0.000 claims abstract description 48
- 239000008280 blood Substances 0.000 claims abstract description 47
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 30
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract description 30
- 239000006228 supernatant Substances 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 28
- 239000000126 substance Substances 0.000 claims description 28
- 239000002504 physiological saline solution Substances 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 16
- 238000000926 separation method Methods 0.000 claims description 15
- 235000019270 ammonium chloride Nutrition 0.000 claims description 14
- 210000004698 lymphocyte Anatomy 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 10
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000001509 sodium citrate Substances 0.000 claims description 8
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 8
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 5
- 102000007625 Hirudins Human genes 0.000 claims description 5
- 108010007267 Hirudins Proteins 0.000 claims description 5
- 229960002897 heparin Drugs 0.000 claims description 5
- 229920000669 heparin Polymers 0.000 claims description 5
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims description 5
- 229940006607 hirudin Drugs 0.000 claims description 5
- 229960001790 sodium citrate Drugs 0.000 claims description 2
- 238000000746 purification Methods 0.000 abstract description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 230000006037 cell lysis Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 31
- 230000008569 process Effects 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 12
- 239000003634 thrombocyte concentrate Substances 0.000 description 11
- 210000002381 plasma Anatomy 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000011017 operating method Methods 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 3
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 3
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 3
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000003399 chemotactic effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940126864 fibroblast growth factor Drugs 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 230000001582 osteoblastic effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001062009 Indigofera Species 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- LBDSXVIYZYSRII-IGMARMGPSA-N alpha-particle Chemical compound [4He+2] LBDSXVIYZYSRII-IGMARMGPSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410508458.8A CN104307208B (zh) | 2014-09-28 | 2014-09-28 | 一种富集纯化血小板的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410508458.8A CN104307208B (zh) | 2014-09-28 | 2014-09-28 | 一种富集纯化血小板的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104307208A true CN104307208A (zh) | 2015-01-28 |
CN104307208B CN104307208B (zh) | 2016-08-24 |
Family
ID=52362603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410508458.8A Active CN104307208B (zh) | 2014-09-28 | 2014-09-28 | 一种富集纯化血小板的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104307208B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105368776A (zh) * | 2015-12-11 | 2016-03-02 | 深圳市职业病防治院 | 阶梯式离心提取血小板的方法 |
CN105462921A (zh) * | 2015-12-31 | 2016-04-06 | 广州赛莱拉干细胞科技股份有限公司 | 一种高效富集血小板的方法 |
CN106890732A (zh) * | 2017-04-07 | 2017-06-27 | 长沙湘智离心机仪器有限公司 | 一种美容离心机及其操作方法 |
CN107446036A (zh) * | 2017-09-25 | 2017-12-08 | 浙江中医药大学 | 一种血小板细胞因子浓集物的富集方法 |
CN107937334A (zh) * | 2017-11-01 | 2018-04-20 | 杭州易文赛生物技术有限公司 | 一种细胞因子提取物及其应用 |
CN108871916A (zh) * | 2018-07-17 | 2018-11-23 | 厦门生命互联科技有限公司 | 一种超纯血小板的分离方法 |
CN110538196A (zh) * | 2019-08-13 | 2019-12-06 | 杭州易文赛生物技术有限公司 | 一种富血小板血浆和提取富血小板血浆的方法 |
CN111388649A (zh) * | 2020-03-19 | 2020-07-10 | 杭州三江上御生物科技有限公司 | 一种富血小板血浆胎盘多肽组合物及其应用 |
CN112237755A (zh) * | 2019-07-18 | 2021-01-19 | 北京纳通医学科技研究院有限公司 | 富血小板血浆的制备方法、制备装置及制得的富血小板血浆 |
CN114015641A (zh) * | 2021-07-13 | 2022-02-08 | 安徽农业大学 | 猪血小板裂解液培养基及其应用 |
CN115633679A (zh) * | 2022-10-24 | 2023-01-24 | 复旦大学附属中山医院 | 富血小板血浆的分离保存液及分离方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107384856A (zh) * | 2017-07-28 | 2017-11-24 | 重庆赛纳思生物科技有限公司 | 一种制备血小板裂解液的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4997486B2 (ja) * | 2004-01-23 | 2012-08-08 | 学校法人慶應義塾 | 脈管障害部位集積性担体 |
CN102755770A (zh) * | 2012-07-30 | 2012-10-31 | 博雅干细胞科技有限公司 | 富血小板血浆的提取方法和提取的富血小板血浆 |
CN103212125A (zh) * | 2013-04-01 | 2013-07-24 | 浙江康慈医疗科技有限公司 | 一种快速提取富血小板高浓度血浆的方法及专用设备 |
CN103505911A (zh) * | 2013-10-15 | 2014-01-15 | 广东省人民医院 | 一种以手工二次离心法制备富血小板血浆的方法 |
-
2014
- 2014-09-28 CN CN201410508458.8A patent/CN104307208B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4997486B2 (ja) * | 2004-01-23 | 2012-08-08 | 学校法人慶應義塾 | 脈管障害部位集積性担体 |
CN102755770A (zh) * | 2012-07-30 | 2012-10-31 | 博雅干细胞科技有限公司 | 富血小板血浆的提取方法和提取的富血小板血浆 |
CN103212125A (zh) * | 2013-04-01 | 2013-07-24 | 浙江康慈医疗科技有限公司 | 一种快速提取富血小板高浓度血浆的方法及专用设备 |
CN103505911A (zh) * | 2013-10-15 | 2014-01-15 | 广东省人民医院 | 一种以手工二次离心法制备富血小板血浆的方法 |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105368776B (zh) * | 2015-12-11 | 2018-11-27 | 深圳市职业病防治院 | 阶梯式离心提取血小板的方法 |
CN105368776A (zh) * | 2015-12-11 | 2016-03-02 | 深圳市职业病防治院 | 阶梯式离心提取血小板的方法 |
CN105462921A (zh) * | 2015-12-31 | 2016-04-06 | 广州赛莱拉干细胞科技股份有限公司 | 一种高效富集血小板的方法 |
CN106890732A (zh) * | 2017-04-07 | 2017-06-27 | 长沙湘智离心机仪器有限公司 | 一种美容离心机及其操作方法 |
CN107446036A (zh) * | 2017-09-25 | 2017-12-08 | 浙江中医药大学 | 一种血小板细胞因子浓集物的富集方法 |
CN107937334A (zh) * | 2017-11-01 | 2018-04-20 | 杭州易文赛生物技术有限公司 | 一种细胞因子提取物及其应用 |
CN108871916A (zh) * | 2018-07-17 | 2018-11-23 | 厦门生命互联科技有限公司 | 一种超纯血小板的分离方法 |
CN112237755A (zh) * | 2019-07-18 | 2021-01-19 | 北京纳通医学科技研究院有限公司 | 富血小板血浆的制备方法、制备装置及制得的富血小板血浆 |
CN112237755B (zh) * | 2019-07-18 | 2023-12-05 | 北京纳通医学科技研究院有限公司 | 富血小板血浆的制备方法、制备装置及制得的富血小板血浆 |
CN110538196A (zh) * | 2019-08-13 | 2019-12-06 | 杭州易文赛生物技术有限公司 | 一种富血小板血浆和提取富血小板血浆的方法 |
CN111388649A (zh) * | 2020-03-19 | 2020-07-10 | 杭州三江上御生物科技有限公司 | 一种富血小板血浆胎盘多肽组合物及其应用 |
CN111388649B (zh) * | 2020-03-19 | 2023-09-12 | 杭州三江上御生物科技有限公司 | 一种富血小板血浆胎盘多肽组合物及其应用 |
CN114015641A (zh) * | 2021-07-13 | 2022-02-08 | 安徽农业大学 | 猪血小板裂解液培养基及其应用 |
CN115633679A (zh) * | 2022-10-24 | 2023-01-24 | 复旦大学附属中山医院 | 富血小板血浆的分离保存液及分离方法 |
CN115633679B (zh) * | 2022-10-24 | 2023-10-31 | 江苏美赛尔生物科技有限公司 | 富血小板血浆的分离保存液及分离方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104307208B (zh) | 2016-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104307208B (zh) | 一种富集纯化血小板的方法 | |
CN102755770B (zh) | 富血小板血浆的提取方法和提取的富血小板血浆 | |
CN106727700A (zh) | 制备富血小板血浆prp的方法及该富血小板血浆的用途 | |
JP6405304B2 (ja) | 脂肪由来幹細胞作製システムおよび方法 | |
CN102604892B (zh) | 一种人类骨髓、脐带血或外周血干细胞样本密度分离液及干细胞分离方法 | |
CN104337835B (zh) | 一种富血小板血浆的制备方法 | |
CN106491544A (zh) | 富血小板血浆冻干粉及制法和用途 | |
CN101638637A (zh) | 人类骨髓、脐带血、外周血细胞处理试剂盒及细胞处理方法 | |
CN107446036A (zh) | 一种血小板细胞因子浓集物的富集方法 | |
CN103710338B (zh) | 一种人类全血白细胞中dna提取试剂盒 | |
CN104558354A (zh) | 一种富血小板血浆分离胶及富血小板血浆制备方法 | |
CN104711226A (zh) | 一种胎盘造血干细胞的制备方法 | |
CN107376427A (zh) | 一种不含外源性添加剂的富血小板血浆制备方法 | |
JP3416779B2 (ja) | ウイルス汚染について血液単位を試験するための方法及び装置 | |
CN112458051A (zh) | 一种外周血单个核细胞的提取收集方法 | |
CN104667362A (zh) | 全自动全血采集分离机及配套的一次性使用采集分离装置 | |
CN106668970A (zh) | 一种白细胞或单核细胞收集用冲洗液及收集装置 | |
CN114196627A (zh) | 一种牛血液cd4+t淋巴细胞的分离方法 | |
CN104762262A (zh) | 一种脐血干细胞的体积离心分离方法 | |
CN102250839A (zh) | 一种通用型细胞处理试剂盒及其应用方法 | |
CN104198669A (zh) | 利用微量溶血分光光度法测定气管炎疫苗免疫活性的方法 | |
CN111172108A (zh) | 一种组织液的制备方法 | |
CN209019542U (zh) | 一种用于脐血、胎盘血及外周血采集与成分分离的装置 | |
CN103842496A (zh) | 制备纯化的干细胞组分的高安全性方法 | |
CN110538196A (zh) | 一种富血小板血浆和提取富血小板血浆的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Dan Letian Inventor after: Tong Peijian Inventor after: Jin Wangdong Inventor after: Jin Hongting Inventor after: Du Wenxi Inventor after: Lang Xiaoli Inventor before: Tong Peijian Inventor before: Dan Letian Inventor before: Jin Hongting Inventor before: Xiao Luwei Inventor before: Jin Wangdong Inventor before: Lang Xiaoli |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201214 Address after: Room 111, building 11, Sanjianghui center, Wenyan street, Xiaoshan District, Hangzhou City, Zhejiang Province Patentee after: Hangzhou Sanjiang Shangyu Biotechnology Co.,Ltd. Address before: Hangzhou City, Zhejiang province Binjiang District 310053 shore road 548 Patentee before: ZheJiang Chinese Medical University |